How is Classic Hodgkin Lymphoma Diagnosed?

Published: Apr 04, 2024

Diagnosing Classic Hodgkin Lymphoma (cHL) involves a series of tests and evaluations. Learn about the crucial steps involved in pinpointing this condition.

Initial Evaluation and Symptoms

The first step in diagnosing cHL is a thorough medical history and physical examination. Doctors look for signs of swollen lymph nodes, fever, night sweats, and weight loss. They also inquire about any history of previous cancers or family history of similar conditions. These initial observations guide the subsequent tests needed for a definitive diagnosis.

Laboratory Tests and Imaging

Blood tests, including a complete blood count (CBC), help detect abnormalities like anemia or elevated white blood cell counts. Imaging tests, such as PET/CT scans, are used to visualize the extent of the disease and identify the best areas for biopsy. These tests are crucial in determining the stage of the disease and guiding treatment plans.

Classic Hodgkin Lymphoma is a type of cancer that affects the lymphatic system, characterized by the presence of Reed-Sternberg cells.

The Importance of Biopsy

A biopsy is essential for confirming a cHL diagnosis. An excisional biopsy, where an entire lymph node is removed, provides the most accurate results. This procedure allows pathologists to examine the tissue under a microscope, looking for the characteristic Hodgkin/Reed-Sternberg cells that define cHL. This step is critical for differentiating cHL from other types of lymphomas.

Frequently Asked Questions

Diagnosis involves blood tests, imaging, and a biopsy.

A biopsy confirms the presence of characteristic cancer cells in cHL.

Imaging helps visualize disease extent and guides biopsy site selection.

Blood tests detect abnormalities that may indicate cHL.

Key Takeaways

Accurate diagnosis of cHL is crucial for effective treatment planning.

Talk with Doctronic to understand more about diagnosing Hodgkin Lymphoma.

Related Articles

References

Cheson BD, Fisher RI, Barrington SF, et al. J Clin Oncol 2014; 32:3059.

Good GR, DiNubile MJ. N Engl J Med 1995; 332:436.

Always discuss health information with your healthcare provider.